NCT01563185 - Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Juvenile Idiopathic Arthritis

Interventions

DRUG

800 mg ibuprofen/26.6 mg famotidine

Oral tablet taken three time per day

Trial Locations (5)

Altoona Center for Clinical Research Altoona Arthritis, Duncansville

Children's Hospital, New Orleans

Dell Children's Medical Center of Central Texas, Austin

Floating Hospital for Children @ Tufts Medical Center, Boston

UMASS Memorial Children's Medical Center, Worcester